ADMA Biologics ADMA Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's operating lease liabilities?
- ADMA Biologics (ADMA) reported operating lease liabilities of $6.37M in Q1 2026.
- How has ADMA Biologics's operating lease liabilities changed year-over-year?
- ADMA Biologics's operating lease liabilities decreased by 23.3% year-over-year, from $8.3M to $6.37M.
- What is the long-term trend for ADMA Biologics's operating lease liabilities?
- Over 5 years (2020 to 2025), ADMA Biologics's operating lease liabilities has grown at a 8.9% compound annual growth rate (CAGR), from $4.33M to $6.65M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.